Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4

Fig. 1

The expression of miR-105-3p in breast cancer tissues and cell lines. a The expression of miR-105-3p in breast cancer and adjacent noncancerous tissues. b The expression of miR-105-3p in breast cancer tissues with different tumour stages. c Kaplan–Meier survival curve analyses among breast cancer patients with different expression levels of miR-105-3p. d The expression level of miR-105-3p in the breast cancer cell lines MCF10A, MDA-MB-231, SKBr-3, MCF-7 and ZR-75-30. e Transfection efficiency of the miR-105-3p miRNA inhibitor and NC inhibitor in MCF-7 and ZR-75-30 cells. f The expression level of miR-105-3p in the MCF-7 and ZR-75-30 cells transfected with miR-105-3p miRNA inhibitor and NC inhibitor. Asterisks indicate significant differences from the control (**P < 0.01, Student’s t-test, compared to normal tissues, breast cancer of stage I + II, the MCF-10A group or the NC inhibitor group)

Back to article page